Table 2 New O patients switching to I, by sex, age group and year of starting O (percent and overall proportion)

From: Treatment of 5-fluorouracil refractory metastatic colorectal cancer: an Australian population-based analysis

 

New patients in 2002

New patients in 2003

Age group

Male (%)

Female (%

Male (%)

Female (%)

<50

46

46

53

55

50–59

45

37

43

41

60–69

45

36

42

37

70–79

34

30

29

24

⩾80

25

0

100

18

Overall

40 (276/697)

40 (401/1 009)

  1. I, irinotecan; O, oxaliplatin.
Back to article page